HCA Healthcare, Inc. (NYSE:HCA) will release its third-quarter 2025 financial results on October 24. Analysts estimate adjusted earnings of $5.72 per share, with sales of$18.57 billion.For the third quarter of 2025, Guggenheim Partners expects HCA Healthcare to deliver EBITDA in line with or slightly above estimates, supported by patient volumes up 2–3% and stable trends from channel checks.The firm notes modest deceleration in August but highlights ongoing favorable payor mix as lower-reimbursing payors r ...